Harbor Capital Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,331
Closed -$108K 816
2023
Q4
$108K Sell
1,331
-357
-21% -$29K 0.02% 411
2023
Q3
$276K Buy
1,688
+451
+36% +$106K 0.06% 318
2023
Q2
$406K Buy
+1,237
New +$377K 0.08% 282

Other funds holding OM

Harbor Capital Advisors's OM Position: Q1 2024 in Review

Harbor Capital Advisors sold out of Outset Medical (OM) in Q1 2024, closing a stake of 1,331 shares — an estimated $108K sold.

Harbor Capital Advisors first reported a position in OM in Q2 2023 and held it in 3 quarters. The position peaked at $406K in Q2 2023. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

  • Harbor Capital Advisors reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 1,331 Outset Medical shares in Q1 2024, an estimated $108K.
  • Harbor Capital Advisors first reported a position in Outset Medical in Q2 2023 and held it in 3 quarters.
  • Harbor Capital Advisors's Outset Medical position peaked at $406K in Q2 2023.
  • 114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Harbor Capital Advisors's 13F filing for Q1 2024, filed 13 May 2024.